RXFILES CORP has a total of 14 patent applications. Its first patent ever was published in 1999. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and United States. Its main competitors in its focus markets pharmaceuticals, medical technology and computer technology are BODYBIO INC, MEDSTAR HEALTH INC and ADARE PHARMACEUTICALS US L P.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | Canada | 3 | |
#3 | United States | 3 | |
#4 | Australia | 1 | |
#5 | Brazil | 1 | |
#6 | Israel | 1 | |
#7 | Norway | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Computer technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Healthcare informatics | |
#3 | Diagnosis and surgery | |
#4 | Therapeutic chemical compounds | |
#5 | Syringes |
# | Name | Total Patents |
---|---|---|
#1 | Mcmichael John | 8 |
#2 | Mcmichael John P | 5 |
#3 | Singer Michaeal G | 4 |
#4 | Kutzko John D | 4 |
#5 | Singer Michael G | 1 |
#6 | Kutzco John D | 1 |
Publication | Filing date | Title |
---|---|---|
CA2401913A1 | Method, apparatus and system for use in treating patient with a drug having an antineoplastic effect to optimize therapy and prevent an adverse drug response | |
WO03011215A2 | Method and system to determine revised dosage | |
US6578582B2 | Method and apparatus using IDS™ for multi-agent therapy | |
CA2419431A1 | Method and system for anticoagulant dose revision | |
US6575169B2 | Method and apparatus for use in treating a patient with any drug to optimize therapy and prevent an adverse drug | |
US6267116B1 | Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug |